{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:37:56Z","timestamp":1790865476443,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1124\/dmd.110.032474","type":"journal-article","created":{"date-parts":[[2010,4,22]],"date-time":"2010-04-22T02:46:37Z","timestamp":1271904397000},"page":"1308-1313","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Methadone: A Substrate and Mechanism-Based Inhibitor of CYP19 (Aromatase)"],"prefix":"10.1016","volume":"38","author":[{"given":"Wenjie Jessie","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Bies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Landry K.","family":"Kamden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeruesenay","family":"Desta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Flockhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.110.032474_bib1","first-page":"171","article-title":"Symptoms related to the menopause and sex steroid treatments","volume":"191","author":"B\u00e4ckstr\u00f6m","year":"1995","journal-title":"Ciba Found Symp"},{"key":"10.1124\/dmd.110.032474_bib2","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1124\/jpet.103.053199","article-title":"Aromatase is the major enzyme metabolizing buprenorphine in human placenta","volume":"306","author":"Deshmukh","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.110.032474_bib3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0376-8716(00)00121-6","article-title":"Plasma concentrations of the enantiomers of methadone and therapeutic response in methadone maintenance treatment","volume":"61","author":"Eap","year":"2000","journal-title":"Drug Alcohol Depend"},{"key":"10.1124\/dmd.110.032474_bib4","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2165\/00003088-200241140-00003","article-title":"Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence","volume":"41","author":"Eap","year":"2002","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/dmd.110.032474_bib5","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1046\/j.1365-2125.1999.00921.x","article-title":"Methadone N-demethylation in human liver microsomes: lack of stereoselectivity and involvement of CYP3A4","volume":"47","author":"Foster","year":"1999","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/dmd.110.032474_bib6","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/j.1399-6576.2008.01597.x","article-title":"Clinical pharmacology of methadone for pain","volume":"52","author":"Fredheim","year":"2008","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1124\/dmd.110.032474_bib7","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1365-2605.2007.00824.x","article-title":"Hypogonadism in men receiving methadone and buprenorphine maintenance treatment","volume":"32","author":"Hallinan","year":"2009","journal-title":"Int J Androl"},{"key":"10.1124\/dmd.110.032474_bib8","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1055\/s-2006-947160","article-title":"Methadone metabolism by early gestational age placentas","volume":"23","author":"Hieronymus","year":"2006","journal-title":"Am J Perinatol"},{"key":"10.1124\/dmd.110.032474_bib9","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1021\/tx7002504","article-title":"Mechanism-based inactivation of human cytochromes p450s: experimental characterization, reactive intermediates, and clinical implications","volume":"21","author":"Hollenberg","year":"2008","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.110.032474_bib10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0300-483X(96)03549-4","article-title":"Interaction of methadone with substrates of human hepatic cytochrome P450 3A4","volume":"117","author":"Iribarne","year":"1997","journal-title":"Toxoicology"},{"key":"10.1124\/dmd.110.032474_bib11","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/S0022-3565(24)35013-X","article-title":"Diltiazem inhibition of cytochrome P-450 3A activity is due to metabolite intermediate complex formation","volume":"290","author":"Jones","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.110.032474_bib12","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2174\/138920007780866807","article-title":"Mechanism-based inactivation of cytochrome P450 enzymes: chemical mechanisms, structure-activity relationships and relationship to clinical drug-drug interactions and idiosyncratic adverse drug reactions","volume":"8","author":"Kalgutkar","year":"2007","journal-title":"Curr Drug Metab"},{"key":"10.1124\/dmd.110.032474_bib13","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/clpt.2008.104","article-title":"Mechanism of ritonavir changes in methadone pharmacokinetics and pharmacodynamics: I. Evidence against CYP3A mediation of methadone clearance","volume":"84","author":"Kharasch","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.110.032474_bib14","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.clpt.2004.05.003","article-title":"Role of hepatic and intestinal cytochrome P450 3A and 2B6 in the metabolism, disposition, and miotic effects of methadone","volume":"76","author":"Kharasch","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.110.032474_bib15","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/ALN.0b013e3181986a9a","article-title":"Methadone pharmacokinetics are independent of cytochrome P4503A (CYP3A) activity and gastrointestinal drug transport: insights from methadone interactions with ritonavir\/indinavir","volume":"110","author":"Kharasch","year":"2009","journal-title":"Anesthesiology"},{"key":"10.1124\/dmd.110.032474_bib16","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.drugalcdep.2006.05.027","article-title":"Low bone density in patients receiving methadone maintenance treatment","volume":"85","author":"Kim","year":"2006","journal-title":"Drug Alcohol Depend"},{"key":"10.1124\/dmd.110.032474_bib17","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1001\/jama.2008.648","article-title":"Methadone maintenance 4 decades later: thousands of lives saved but still controversial","volume":"300","author":"Kleber","year":"2008","journal-title":"JAMA"},{"key":"10.1124\/dmd.110.032474_bib18","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1592\/phco.23.6.802.32186","article-title":"Dose-related effects of methadone on QT prolongation in a series of patients with torsade de pointes","volume":"23","author":"Krantz","year":"2003","journal-title":"Pharmacotherapy"},{"key":"10.1124\/dmd.110.032474_bib19","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00000433-199506000-00002","article-title":"Site dependence of postmortem blood methadone concentrations","volume":"16","author":"Levine","year":"1995","journal-title":"Am J Forensic Med Pathol"},{"key":"10.1124\/dmd.110.032474_bib20","series-title":"Methadone Pharmacology.","author":"Morton","year":"2007"},{"key":"10.1124\/dmd.110.032474_bib21","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.bcp.2004.04.011","article-title":"Methadone metabolism by human placenta","volume":"68","author":"Nanovskaya","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.110.032474_bib22","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/0003-9861(81)90239-3","article-title":"Selective inactivation of cytochrome P-450 isoenzymes by suicide substrates","volume":"210","author":"Ortiz de Montellano","year":"1981","journal-title":"Arch Biochem Biophys"},{"key":"10.1124\/dmd.110.032474_bib23","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0960-0760(97)80002-7","article-title":"Diverse function of aromatase and the N-terminal sequence deleted form","volume":"61","author":"Osawa","year":"1997","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1124\/dmd.110.032474_bib24","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1021\/jm00285a004","article-title":"Synthesis and identification of metabolites resulting from the biotransformation of dl-methadone in man and in the rat","volume":"14","author":"Pohland","year":"1971","journal-title":"J Med Chem"},{"key":"10.1124\/dmd.110.032474_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-3565(25)21130-2","article-title":"Altered methadone pharmacokinetics in methadone-maintained pregnant women","volume":"233","author":"Pond","year":"1985","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.110.032474_bib26","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3109\/10826088509047754","article-title":"Methadone maintenance treatment","volume":"20","author":"Senay","year":"1985","journal-title":"Int J Addict"},{"key":"10.1124\/dmd.110.032474_bib27","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s12098-008-0107-5","article-title":"Neonatal abstinence syndrome","volume":"75","author":"Serane","year":"2008","journal-title":"Indian J Pediatr"},{"key":"10.1124\/dmd.110.032474_bib28","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2125.2008.03312.x","article-title":"Contribution of the activities of CYP3A, CYP2D6, CYP1A2 and other potential covariates to the disposition of methadone in patients undergoing methadone maintenance treatment","volume":"67","author":"Shiran","year":"2009","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/dmd.110.032474_bib29","series-title":"Mechanism Based Inactivation: Chemistry and Enzymology.","author":"Silverman","year":"1988"},{"key":"10.1124\/dmd.110.032474_bib30","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.jbi.2006.10.004","article-title":"Surveillance of methadone-related adverse drug events using multiple public health data sources","volume":"40","author":"Sims","year":"2007","journal-title":"J Biomed Inform"},{"key":"10.1124\/dmd.110.032474_bib31","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/0024-3205(81)90617-2","article-title":"Disposition of methadone in the ovine maternal-fetal unit","volume":"28","author":"Szeto","year":"1981","journal-title":"Life Sci"},{"key":"10.1124\/dmd.110.032474_bib32","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/ALN.0b013e3181642938","article-title":"Role of CYP2B6 in stereoselective human methadone metabolism","volume":"108","author":"Totah","year":"2008","journal-title":"Anesthesiology"},{"key":"10.1124\/dmd.110.032474_bib33","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1124\/dmd.31.6.742","article-title":"Involvement of CYP3A4, CYP2C8, and CYP2D6 in the metabolism of (R)- and (S)-methadone in vitro","volume":"31","author":"Wang","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.110.032474_bib34","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1526-4637.2006.00289.x","article-title":"Actual and potential drug interactions associated with methadone","volume":"9","author":"Weschules","year":"2008","journal-title":"Pain Med"},{"key":"10.1124\/dmd.110.032474_bib35","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1056\/NEJMra032424","article-title":"Drug metabolism and variability among patients in drug response","volume":"352","author":"Wilkinson","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1124\/dmd.110.032474_bib36","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.bcp.2005.12.035","article-title":"The effect of methadone and buprenorphine on human placental aromatase","volume":"71","author":"Zharikova","year":"2006","journal-title":"Biochem Pharmacol"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624024310?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624024310?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.110.032474","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T16:50:47Z","timestamp":1739897447000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624024310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0090955624024310"],"URL":"https:\/\/doi.org\/10.1124\/dmd.110.032474","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Methadone: A Substrate and Mechanism-Based Inhibitor of CYP19 (Aromatase)","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.110.032474","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2010 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}